GIP + GLP-1 pathway support
Tirzepatide
Tirzepatide acts on GIP and GLP-1 receptors involved in appetite and food-intake signaling. A licensed clinician reviews your health history, goals, and current medications before deciding whether treatment and a particular dose are appropriate.
Weekly dose & supply
- 2.5 mg weekly · 8 weeks
- 5 mg weekly · 4 weeks
Only as prescribed after clinical evaluation. These are alternative supply options, not a dose-escalation schedule. Follow the dispensing pharmacy’s storage and discard instructions.
- Individual eligibility review
- Secure card setup with no charge today
- Clinical consultation before prescribing
Licensed review
A clinician evaluates your history, current medications, and treatment goals.
Coordinated fulfillment
If prescribed and the authorized charge succeeds, VitaCare coordinates fulfillment and included standard shipping.
Assessment after card setup
After Square securely saves the card, the medical assessment opens as the next required step.
Important treatment information
Do not start, stop, or change a medication based on this page. Discuss risks, contraindications, possible adverse effects, and alternatives with your clinician. Seek emergency care for urgent symptoms.